Use of PRO Onc Assay to Assess HER2 in Patients With Metastatic Breast Cancer

This study is currently recruiting participants.
Verified April 2014 by SCRI Development Innovations, LLC
Sponsor:
Collaborators:
Prometheus Laboratories
Genentech
Information provided by (Responsible Party):
SCRI Development Innovations, LLC
ClinicalTrials.gov Identifier:
NCT01048099
First received: January 12, 2010
Last updated: April 16, 2014
Last verified: April 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2016
  Estimated Primary Completion Date: August 2016 (Final data collection date for primary outcome measure)